These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Renoprotective effects of hepatocyte growth factor in the stenotic kidney. Stewart N; Chade AR Am J Physiol Renal Physiol; 2013 Mar; 304(6):F625-33. PubMed ID: 23269649 [TBL] [Abstract][Full Text] [Related]
46. Pharmacoangiographic manipulation of renal collateral blood flow. Bookstein JJ; Walter JF; Stanley JC; Fry WJ Circulation; 1976 Aug; 54(2):328-34. PubMed ID: 939030 [TBL] [Abstract][Full Text] [Related]
47. [Renal course in the hypertensive patient]. Zucchelli P; Chiarini C; Degli Esposti E; Sturani A; Santoro A; Zuccalà A Minerva Urol Nefrol; 1984; 36(4 Suppl):31-6. PubMed ID: 6535289 [No Abstract] [Full Text] [Related]
48. Hemodynamic Versus Anatomic Assessment of Symptomatic Atherosclerotic Middle Cerebral Artery Stenosis: the Relationship Between Pressure Wire Translesional Gradient and Angiographic Lesion Geometry. Li L; Yang B; Dmytriw AA; Wang T; Luo J; Li Y; Ma Y; Chen J; Wang Y; Gao P; Feng Y; Bai X; Zhang X; Dong J; Yang R; Jiao L; Ling F Front Neurol; 2021; 12():671778. PubMed ID: 34456841 [No Abstract] [Full Text] [Related]
49. Vasodilatory and vasoconstrictive pharmacoangiographic manipulation of renal collateral flow. Bookstein JJ; Ernst CB Radiology; 1973 Jul; 108(1):55-9. PubMed ID: 4709048 [No Abstract] [Full Text] [Related]
50. Fluid restitution and blood volume redistribution in anesthetized rabbits in response to vasoactive drugs. Anderson SM; Rich GF; Roos C; Lee LP; Lee JS Circulation; 1994 Jul; 90(1):509-14. PubMed ID: 8026040 [TBL] [Abstract][Full Text] [Related]
53. Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use? Chade AR; Stewart N J Am Soc Hypertens; 2013; 7(2):180-90. PubMed ID: 23428409 [TBL] [Abstract][Full Text] [Related]
56. The use of video imaging techniques to study ultrafiltration and blood flow in the normal and diseased kidney. Savin VJ Int Rev Exp Pathol; 1988; 30():321-55. PubMed ID: 3061962 [No Abstract] [Full Text] [Related]
57. [A neurovascular unit as a point of action of some vasoactive and neuroprotective drugs]. Kasatkin DS Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):103-7. PubMed ID: 23373082 [No Abstract] [Full Text] [Related]
58. Increased platelet adhesiveness in hypertensive cardiovascular disease. Poplawski A; Skorulska M; Niewiarowski S J Atheroscler Res; 1968; 8(4):721-3. PubMed ID: 5679953 [No Abstract] [Full Text] [Related]
59. Drug-induced changes in blood pressure and in blood sodium as measured by glass electrode. FRIEDMAN SM; JAMIESON JD; HINKE JA; FRIEDMAN CL Am J Physiol; 1959 May; 196(5):1049-52. PubMed ID: 13649929 [No Abstract] [Full Text] [Related]
60. Pressor substances in kidneys of renal hypertensive rats with and without adrenals. GROSS F; LICHTLEN P Proc Soc Exp Biol Med; 1958 Jun; 98(2):341-5. PubMed ID: 13554639 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]